Bandhan Healthcare Fund NFO Opens on November 10, 2025

The Bandhan Healthcare Fund NFO, launching on November 10, 2025 and closing on November 24, 2025, offers investors an opportunity to participate in India’s growing healthcare and pharmaceutical sectors. Designed as an open-ended equity scheme, the fund aims to generate long-term capital appreciation by investing predominantly in equities and equity-related instruments of companies engaged in healthcare, pharma, and allied sectors. With a minimum investment of ₹1,000 and no exit load after 30 days, the fund is well-suited for investors seeking wealth creation over the long term. The scheme also provides options for systematic investment plans (SIPs) starting at ₹100, making it accessible to a wide range of investors.

Key Features of Bandhan Healthcare Fund

Invest in Indian Markets and Unlock Future Potential With 5paisa!

Open Account Now

• Open Date: November 10, 2025
• Close DateNovember 24, 2025
• Exit Load: Nil if redeemed after 30 days; 0.5% if redeemed within 30 days
• Minimum Investment: ₹1,000 lump sum; SIP from ₹100 (minimum 6 installments)

Objective of the NFO

The Bandhan Healthcare Fund - Direct (G) seeks to generate long-term capital appreciation by investing primarily in equities and equity-related instruments of companies operating in the healthcare, pharmaceutical, and allied sectors. The scheme does not guarantee returns, and investments are subject to market risks, but it targets growth through a sector-focused, research-driven approach.

Investment Strategy of Bandhan Healthcare Fund

• Actively managed equity scheme focusing on healthcare, pharma, and allied companies
• Flexibility to invest across market capitalisation segments, including large, mid, and small-cap stocks
• Bottom-up stock selection approach based on company fundamentals, business model, financial strength, and governance standards
• Investments across sectors such as pharmaceuticals, hospitals, biotechnology, medical equipment, healthcare services, research, analytics, technology, retail pharmacy, and wellness
• Use of derivatives permitted for hedging and portfolio balancing, in line with SEBI guidelines

Risks Associated with Bandhan Healthcare Fund

• Concentration risk due to sectoral focus on healthcare and pharma
• Regulatory and pricing risks affecting pharmaceutical companies
• Potential non-compliance in international markets for generic drug manufacturers
• Market volatility and unexpected changes are impacting sector performance
• Liquidity risk in equity markets and unlisted securities
• Derivative instruments may lead to disproportionate gains or losses
• Risks related to interest rates, credit quality, and foreign currency exposure for any overseas investments

Risk Mitigation Strategy by Bandhan Healthcare Fund

The fund follows a comprehensive risk management approach to limit exposure to market, sectoral, and liquidity risks. Strategies include diversifying investments across multiple companies and sub-sectors, maintaining a focus on liquid securities, and using derivatives for hedging purposes. Quality assessment ensures only robust, financially stable, and well-governed companies are included in the portfolio. The fund also monitors interest rate and credit risks in debt or money market instruments, while overseas investments are restricted to stable currencies and liquid securities. Continuous monitoring and active portfolio management aim to reduce volatility and protect investor capital over the long term.

What Type of Investor Should Invest in Bandhan Healthcare Fund?

• Investors seeking long-term capital appreciation through equity exposure
• Individuals comfortable with higher volatility and sector-specific risk
• Those looking to invest in healthcare, pharmaceutical, and allied sectors
• Suitable for investors with a medium to long-term investment horizon of 5 years or more

Where Will the Bandhan Healthcare Fund Invest?

• Equity and equity-related instruments of companies in healthcare, pharmaceuticals, biotechnology, hospitals, and medical equipment
• Healthcare service providers, pharmacy retail chains, wellness companies, and research or analytics firms
• Derivative instruments for hedging and portfolio management, as per SEBI regulations
• Select overseas securities with stable currencies, while adhering to prescribed investment limits
• Liquid debt and money market instruments to manage risk and liquidity needs